Internet of Things - IOT

This study describes and analyzes the biotechnology industry, focusing on biotechnology therapeutics. The study includes a discussion of drivers, restrains, technologies, research and development, manufacturing, regulatory issues, products, partnerships and capital markets. This study also presents a startegy framework that identifies key compete...

This research service provides an overview of the pharma-biotech industry in terms of critical success factors and alliance management.

This research service provides the market information on the global radiotherapy and radiosurgery markets, with specific focus on the United States.

This issue of Vital Signs, released on August 23, 2010, provides a strategic analysis of trends in biomarkers for improved and accelerated sepsis treatment. Additionally, a company spotlight is provided for BRAHMS, a global biotechnology company committed to improving healthcare through the discovery and development of novel and innovative bio...

This deliverable provides insights on the many macro issues facing the pharma and biotech industry. The industry is currently in a state of transition and is faced with a myraid of challenges including the dreaded patent cliff. This research service presents a total market forecast, market share analysis by leading companies, top therapeutic class...

The global healthcare industry is undergoing a transformation from being provider-centric to being more patient-centric by focusing more on the outcomes and value of care delivered. This Research Service (RS) extensively evaluates a business case for technologies that enable better hospital design and strategic business models for healthcare enterp...

Despite the term patient centricity gaining currency in the industry, there is a degree of variability in a companies’ approach and strategic priorities. Frost & Sullivan sees digitization playing a critical role in transforming the clinical trial model from traditional, high-cost, and difficult-to-access centralized settings to more patient-cent...

The study is a comprehensive analysis of the key forces shaping the global medtech industry in 2018 and the resultant themes that would govern the market dynamics in 2019 and beyond. The key medtech industry challenges of lack of innovation in conventional segments, increasing focus on efficiencies, changing device ecosystem to digital enablers, em...

15 to 20 million new cases of cancer are diagnosed every year. Radiotherapy is the gold standard for treatment and is used on more than 3.5 million people and provided as palliative or adjunct treatment for an additional 3.5 million people, worldwide. Nearly 50 percent of all cancer patients are estimated to benefit from radiotherapy for disease ma...